Carolyn YeagoAssociate Director of Research at Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, USA
Carolyn Yeago, Ph.D. is a Principle Scientist and Associate Director of Research at the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) at Georgia Institute of Technology, and also serves as a co-Industry Liaison Officer for the National Science Foundation Engineering Research Center for Cell Manufacturing (CMaT). She brings a unique background to these roles, with significant industry experience in medical and combination devices, including early stage technology development and assessment, business development, and strategic marketing to inform new product platform acquisitions. Dr. Yeago is responsible for overseeing research and development activities supported by the MC3M, leads a team of scientists to advance the clinical use and commercial production of therapeutic cells, and helps build and integrate industry consortium members to advise impactful research and development activities.
Dr. Yeago returned to Georgia Tech after 7 years with Halyard Health and Kimberly Clark Health Care where she directed research and evaluated technologies to inform new platform strategies. She managed multiple projects and cross-functional teams spanning a variety of areas, including nanoparticle development and performance for long-lasting local anesthetic delivery, fundamental research on nerve damage and regeneration post radio-frequency ablation, and organic and inorganic growth strategies for digestive health and wound healing businesses. Dr. Yeago brings a passion for connecting related research and ensuring commercial relevance and translation.
She received her Ph.D. in Biomedical Engineering from the Georgia Institute of Technology and Emory University, her B.S. in Biomedical and Bioengineering from North Carolina State University, and her graduate research focused on hydrodynamic modulation of embryonic stem cell differentiation.